DermBiont, Inc. | LinkedIn (original) (raw)

``

Biotechnology Research

Boston, Massachusetts 3,810 followers

Advancing targeted topical therapeutics for dermatological indications

About us

DermBiont’s mission is to become the world’s leading precision dermatology company developing and commercializing targeted topical therapeutics that treat, cure, and prevent diseases. The company aims to impact the root causes of skin diseases through the development of targeted small molecule therapeutics with well-defined mechanisms of action and biotherapeutics that repair an imbalance of the microbiome. The company’s targeted topical therapeutics pipeline includes SM-020 for the treatment of seborrheic keratosis, SM-030 for the treatment of hyperpigmentation disorders of the skin, and DBI-001 & DBI-002 for the treatment of atopic dermatitis, tinea pedis, and onychomycosis. For more information, please visit www.dermbiont.com.

Industry

Biotechnology Research

Company size

51-200 employees

Headquarters

Boston, Massachusetts

Type

Privately Held

Founded

2017

Locations

Employees at DermBiont, Inc.

Updates

Join now to see what you are missing

Join now

Similar pages

Browse jobs

Funding